Ortin Global
ORTINGLOBE · Pharma > Pharmaceuticals & Drugs · MD: S Murali Krishna Murthy · Listing date: Aug. 21, 2015

Stock Price vs Company Growth
1d
4.6%
1w
0.2%
1m
4.3%
3m
9.3%
6m
6.2%
1y
6.2%
5y
16.0%
all
4.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 18.9 4.6%
17.5
25
Company Overview

Sales
81.9 Cr
Growth: 70.3%
Profit after Tax
0.52 Cr
Growth: -59.5%
Micro Cap
15.3 Cr
P/E: 62.9x
Industry P/E: 35.6x
Fundamentals

Sales (Cr) ₹ 81.9
Growth 70.3%
EBITDA 7.9%
P/S 0.2x
Dividend 0.0%
P/E 62.9x
Book Value ₹ 25.4
PEG Ratio 0.9x
ROE 2.4%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Sanka Venkata Ratnamma
2.37 %
Sanka Balaji Venkateswarlu
1.88 %
Sanka Murali Krishna Murthy
1.65 %
Sanka Srinivas Kumar
1.63 %
Sanka Venkata Sujatha
1.5 %
Others
Rajesh Poddar
4.69 %
Korripati Pullaiah
3.06 %
Shabbir Nazmuddin Paratha
1.75 %
Survival Technologies Private Ltd
1.24 %
Bp Equities Private Limited
1.03 %
Increase    Decrease    No change
Company Profile Detailed

Ortin Laboratories established in the year 1986 was a private limited company with a nominal capital of Rs 1 lakh to offer quality drugs and medicines to the suffering mankind. Later, in the year 1994, this private limited company converted as a public limited company with 5,060 shareholders which received good subscription from the public.
Investors (79)